Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.

Kim CH, Choi KJ, Yoo SS, Lee SY, Won DI, Lim JO, Cha SI, Park JY, Lee J.

Cytometry B Clin Cytom. 2014 Jul;86(4):236-43. doi: 10.1002/cyto.b.21110. Epub 2013 Aug 19.

2.

Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.

Kim CH, Choi KJ, Yoo SS, Lee SY, Won DI, Lim JO, Cha SI, Park JY, Lee J.

Cytometry B Clin Cytom. 2013 Jul 3. doi: 10.1002/cytob.21110. [Epub ahead of print]

3.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
4.

Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Sauzullo I, Scrivo R, Mengoni F, Ermocida A, Coppola M, Valesini G, Vullo V, Mastroianni CM.

Clin Exp Immunol. 2014 Jun;176(3):410-7. doi: 10.1111/cei.12290.

5.

Flow cytometric measurements of TB-specific T cells comparing with QuantiFERON-TB gold.

Won DI, Park JR.

Cytometry B Clin Cytom. 2010 Mar;78(2):71-80. doi: 10.1002/cyto.b.20503.

6.

In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.

Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, Iannetta M, Marocco R, Del Borgo C, Soscia F, Vullo V, Mastroianni CM.

PLoS One. 2009;4(4):e5187. doi: 10.1371/journal.pone.0005187. Epub 2009 Apr 13.

7.

The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.

Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2013 Apr;52(4):697-704. doi: 10.1093/rheumatology/kes365. Epub 2012 Dec 22.

PMID:
23264552
8.

[The clinical application of quantiferon TB-2G: its usefulness and limitations].

Sato S, Nagai H.

Kekkaku. 2011 Feb;86(2):101-12. Japanese.

PMID:
21404654
9.

Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.

Sauzullo I, Mengoni F, Ermocida A, Massetti AP, D'Agostino C, Russo G, Salotti A, Falciano M, Vullo V, Mastroianni CM.

New Microbiol. 2014 Apr;37(2):153-61. Epub 2014 Apr 1.

10.

Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S, Magnavita N, Fadda G, Girardi E, Goletti D.

PLoS One. 2011 Mar 29;6(3):e18315. doi: 10.1371/journal.pone.0018315.

11.

Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.

Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M.

J Infect. 2009 Mar;58(3):197-204. doi: 10.1016/j.jinf.2008.08.009. Epub 2008 Oct 10.

PMID:
18848730
12.

Comparison of whole-blood interferon-γ assay and flow cytometry for the detection of tuberculosis infection.

Lee J, Lee SY, Won DI, Cha SI, Park JY, Kim CH.

J Infect. 2013 Apr;66(4):338-45. doi: 10.1016/j.jinf.2012.08.020. Epub 2012 Sep 23.

PMID:
23010554
13.

Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.

Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M.

Lung. 2010 Aug;188(4):283-7. doi: 10.1007/s00408-010-9238-3. Epub 2010 Apr 27.

14.

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.

Kabeer BS, Raja A, Raman B, Thangaraj S, Leportier M, Ippolito G, Girardi E, Lagrange PH, Goletti D.

BMC Infect Dis. 2011 May 19;11:135. doi: 10.1186/1471-2334-11-135.

15.

Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states.

Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, Lalvani A, Sester M.

PLoS One. 2011 Mar 15;6(3):e17813. doi: 10.1371/journal.pone.0017813.

16.
17.

Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis.

Leung WL, Law KL, Leung VS, Yip CW, Leung CC, Tam CM, Kam KM.

Clin Vaccine Immunol. 2009 Mar;16(3):344-51. doi: 10.1128/CVI.00159-08. Epub 2009 Jan 7.

18.

Flow cytometry analysis of CD4+IFN-γ+ T-cells for the diagnosis of mycobacterium tuberculosis infection.

Papageorgiou CV, Anastasopoulos A, Ploussi M, Leventopoulos M, Karabela S, Fotiadis K, Papavasileiou A, Vogiatzakis E, Ioakeimidis D, Gritzapis AD, Poulakis N.

Cytometry B Clin Cytom. 2016 May;90(3):303-11. doi: 10.1002/cyto.b.21275. Epub 2015 Sep 8.

19.

Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.

Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J, Zhou Z, Huang H, Shao L, Jin J, Weng X, Zhang Y, Zhang W.

PLoS One. 2012;7(12):e51338. doi: 10.1371/journal.pone.0051338. Epub 2012 Dec 14.

20.

Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.

Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, Matteucci G, Lauria FN, Franken KL, Girardi E, Ottenhoff TH, Goletti D.

PLoS One. 2011;6(11):e27539. doi: 10.1371/journal.pone.0027539. Epub 2011 Nov 10.

Supplemental Content

Support Center